DuPont

Healthcare & Water Technologies has recurring, specification‑driven demand with secular tailwinds from biopharma, medical devices, water scarcity and regulation. Diversified Industrials serves auto, building and aerospace; auto and construction introduce macro cyclicality and tariff sensitivity.

Management’s 2025 guidance and 2026‑2028 framework imply modest organic growth and high cash conversion, supporting medium predictability post‑spin. Completion of the Qnity separation and the agreed aramids sale reduces exposure to more volatile profit streams, while leaving manageable cyclical elements.